Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when BTSG files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsBrightSpring raises 2026 guidance after Q3 revenue jumps 26.4% to $4.2B
Filed October 30, 2026 · Period ending October 30, 2026 · ~1 min read
Key Changes
-
high
Q3 2026 net revenue rose 26.4% year-over-year to $4,213 million, driven by Pharmacy Solutions and Provider Services.
Exhibit 99.1 view on EDGAR → -
high
Net income from continuing operations more than doubled to $101 million from $38 million in Q3 2025.
Exhibit 99.1 view on EDGAR → -
high
Adjusted EBITDA climbed 42.0% to $228 million, with leverage improving to 1.79x from 2.15x at June 30.
Exhibit 99.1 view on EDGAR → -
high
Full-year 2026 revenue guidance raised to $15,900–$16,125 million, implying 23.2%–24.9% growth.
Exhibit 99.1 view on EDGAR → -
high
Full-year 2026 Adjusted EBITDA guidance increased to $850–$860 million, or 37.6%–39.3% growth.
Exhibit 99.1 view on EDGAR →
Summary
BrightSpring Health Services reported strong third-quarter 2026 results, with revenue up 26.4% to $4,213 million and net income from continuing operations more than doubling to $101 million. Adjusted EBITDA rose 42.0% to $228 million, and leverage improved to 1.79x. The company raised its full-year 2026 guidance for both revenue and Adjusted EBITDA, reflecting continued momentum across its Pharmacy Solutions and Provider Services segments.
For retail investors, the raised guidance and improved profitability signal management's confidence in the business trajectory. The results exclude the divested Community Living business, so comparisons are on a continuing-operations basis. The company also noted the Amedisys and LHC branches acquisition is expected to contribute approximately $35 million in Adjusted EBITDA in 2026, providing additional visibility into future growth.
Section-by-Section Diff
Event · Exhibit 99.1
Added in current filing · view on EDGAR →
Revenues of $15,900 million to $16,125 million, or 23.2% to 24.9% growth
BrightSpring raised its full-year 2026 revenue guidance to a range of $15,900 million to $16,125 million, representing 23.2% to 24.9% growth compared to full-year 2025 results excluding the Community Living business. The company also increased its full-year Adjusted EBITDA guidance to $850 million to $860 million, or 37.6% to 39.3% growth.
Added in current filing · view on EDGAR →
Total Adjusted EBITDA3 of $850 million to $860 million, or 37.6% to 39.3% growth
The company raised its full-year 2026 Adjusted EBITDA guidance to $850 million to $860 million, implying 37.6% to 39.3% growth over 2025. The Amedisys and LHC branches acquisition is expected to contribute approximately $35 million in Adjusted EBITDA in 2026.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Nov 2, 2026 · How we verify